Discover published sets by community

Damages bacterial DNA, primarily used for urinary tract infections caused by Escherichia coli and Staphylococcus saprophyticus.

Disrupts the outer cell membrane of Gram-negative bacteria by binding to lipopolysaccharide and phospholipids, used as a 'last-resort' antibiotic.

Inhibits DNA gyrase and topoisomerase IV, has a broad spectrum of activity including pseudomonas.

Macrolide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit, used for respiratory infections, some STIs, and more.

Inhibits the synthesis of mycolic acid in the mycobacterial cell wall, used specifically against Mycobacterium tuberculosis.

Inserts into the bacterial cell membrane and causes rapid depolarization, leading to inhibition of protein, DNA, and RNA synthesis, used against Gram-positive bacteria.

Macrolide that inhibits bacterial protein synthesis by binding to the 50S subunit, used for respiratory tract infections and more.

Inhibits protein synthesis by binding to the 50S ribosomal subunit, broad-spectrum activity but used as a last resort due to toxicity.

Inhibits RNA polymerase sigma subunit, targeting Clostridium difficile.

Inhibits bacterial cell wall synthesis, primarily targets Gram-positive bacteria.

Inhibits protein synthesis by binding to the 30S subunit of the bacterial ribosome, used against a broad spectrum of bacteria.

Fluoroquinolone that inhibits DNA gyrase and topoisomerase IV, effective against Gram-negative and some Gram-positive bacteria.

Inhibits protein synthesis by binding to the 50S ribosomal subunit, used mainly for anaerobic infections and Gram-positive cocci.

Inhibits protein synthesis by binding to the 30S ribosomal subunit, effective against a variety of Gram-positive and Gram-negative bacteria.

Inhibits cell wall synthesis by binding to penicillin-binding proteins, used against Gram-positive and some Gram-negative bacteria.

Inhibits cell wall synthesis, effective against Gram-positive cocci.

Causes DNA strand breaks and loss of helical DNA structure, effective against anaerobic bacteria and protozoa.

Inhibits cell wall synthesis by binding to the D-alanyl-D-alanine portion of cell wall precursors, targets MRSA and Gram-positive bacteria.

Inhibits folic acid synthesis pathway, effective against a broad spectrum of Gram-positive and Gram-negative organisms.

Binds to ergosterol, creating pores in the fungal cell membrane, primarily used for cutaneous, oral, or intestinal Candida infections.

Inhibits protein synthesis by binding to the 23S portion of the 50S subunit, used for Gram-positive infections including VRE and MRSA.

Aminoglycoside that inhibits protein synthesis by binding to the 30S subunit, targets Gram-negative bacilli.

Inhibits DNA-dependent RNA polymerase, used for tuberculosis and as prophylaxis for meningococcus and Haemophilus influenzae type b.

Inhibits fungal cytochrome P450 enzyme (14-alpha demethylase), reducing conversion of lanosterol to ergosterol, used for Candida infections and more.